Di(Hydroxyethyl)Ether

Di(Hydroxyethyl)Ether

SCHEMBL607622

CC(S)CC(=O)O.CC(S)CC(=O)O.OCCOCCO

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.42
MAPK1 P28482 1/20 0.42
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
ALDH1A1 P00352 2/20 0.36
MAPT P10636 2/20 0.33
THRB P10828 1/20 0.33
HTT P42858 1/20 0.33
TDP1 Q9NUW8 2/20 0.32
LMNA P02545 1/20 0.32
PTGS2 P35354 1/20 0.32
SLC22A6 Q4U2R8 1/20 0.32
CACNA2D1 P54289 2/20 0.31
CACNB3 P54284 1/20 0.31
CACNA1C Q13936 1/20 0.31
PGR P06401 1/20 0.31
ADRA1A P35348 1/20 0.31
HTR2B P41595 1/20 0.31
CACNA2D2 Q9NY47 1/20 0.31
RNPEP Q9H4A4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Triethylene Glycol SCHEMBL15380518 0.98 MEN1 (0.44) TSHRMAPK1MEN1KMT2AALDH1A1
SCHEMBL28005449 0.88 MEN1 (0.35) TSHRMAPK1MEN1KMT2AMAPT
Ethylene Glycol SCHEMBL29687230 0.84 SLC22A6 (0.39) ALDH1A1MAPTTDP1LMNAPTGS2
Ethylene Glycol SCHEMBL869747 0.84 SLC22A6 (0.39) ALDH1A1MAPTTDP1LMNAPTGS2
SCHEMBL20474986 0.83 TDP1 (0.32) MEN1KMT2AALDH1A1MAPTTDP1
3-Methylbutanoic Acid SCHEMBL27568675 0.83 TSHR (0.46) TSHRMAPK1MEN1KMT2AALDH1A1
SCHEMBL98745 0.82
SCHEMBL8612540 0.82
SCHEMBL20966262 0.82
1,3-Propanediol SCHEMBL868133 0.80 CAMK2A (0.40) ALDH1A1MAPTTDP1LMNAPTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 170 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7989567-B2 Method for production of water/oil repellent composition and article ASAHI GLASS COMPANY, LIMITED (JP) 2011-08-02 US claimed
US-12637544-B2 UV curable silicone composition and cured product thereof DUROPTIX MATERIALS KABUSHIKI KAISHA (JP) 2026-05-26 US disclosed
US-12624279-B2 Quantum dot-containing polymerizable composition, cured product, wavelength conversion member, backlight unit, and liquid crystal display device FUJIFILM CORPORATION (JP) 2026-05-12 US disclosed
EP-4703778-A1 WAVELENGTH CONVERSION SHEET, BACKLIGHT, AND LIQUID CRYSTAL DISPLAY DEVICE Dai Nippon Printing Co., Ltd. (JP) 2026-03-04 EP disclosed
US-12565548-B2 Compound, polymerizable composition, and cured product FUJIFILM CORPORATION (JP) 2026-03-03 US disclosed
EP-4202505-B1 BARRIER FILM, AND WAVELENGTH CONVERSION SHEET, BACKLIGHT, AND LIQUID CRYSTAL DISPLAY DEVICE IN WHICH SAME IS USED, AS WELL AS METHOD FOR SELECTING BARRIER FILM DAINIPPON PRINTING CO LTD (JP) 2026-02-18 EP disclosed
US-12534563-B2 Block copolymer, resin composition, stretch conductor, electronic device, and pressure-sensitive adhesive film ARTIENCE CO., LTD. (JP) 2026-01-27 US disclosed
EP-4201667-B1 BARRIER FILM, AND WAVELENGTH CONVERSION SHEET, BACK LIGHT, AND LIQUID CRYSTAL DISPLAY DEVICE WHICH USE SAME DAINIPPON PRINTING CO LTD (JP) 2025-12-17 EP disclosed
US-12496802-B2 Barrier film, wavelength conversion sheet using same, backlight and liquid crystal display device DAI NIPPON PRINTING CO., LTD. (JP) 2025-12-16 US disclosed
US-12492293-B2 Multi-component systems for preparing foamed products ARKEMA FRANCE (FR) 2025-12-09 US disclosed
EP-2055726-A1 THIOURETHANE COMPOUND AND PHOTOSENSITIVE RESIN COMPOSITION Showa Denko K.K. (JP) 2009-05-06 EP disclosed
US-20090023831-A1 Curable Composition Containing Thiol Compound SHOWA DENKO K.K. (JP) 2009-01-22 US disclosed
EP-1983017-A1 CURABLE COMPOSITION CONTAINING THIOL COMPOUND Showa Denko K.K. (JP) 2008-10-22 EP disclosed
EP-1629046-B1 CURABLE POLYMER COMPOUND SHOWA DENKO KK (JP) 2008-05-14 EP disclosed
US-7341828-B2 Thiol compound, photopolymerization initiator composition and photosensitive composition SHOWA DENKO K.K. (JP) 2008-03-11 US disclosed
US-20070021571-A1 Curable polymer compound SHOWA DENKO K.K. (JP) 2007-01-25 US disclosed
US-20060079593-A1 Hexaarylbiimidazole compounds and photopolymerization initiator compositions containing the same SHOWA DENKO K.K. (JP) 2006-04-13 US disclosed
US-20060041053-A1 Color filter black matrix resist composition and carbon black dispersion composition used for the composition SHOWA DENKO K.K. (JP) 2006-02-23 US disclosed
US-20060036023-A1 Color filter black matrix resist composition SHOWA DENKO K.K. (JP) 2006-02-16 US disclosed
US-20050153231-A1 Thiol compound, photopolymerization initiator composition and photosensitive composition SHOWA DENKO K.K. (JP) 2005-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12637544-B2 UV curable silicone composition and cured product thereof QSOX1, MGMT, TST TSHR 3875/4885MAPK1 1894/4885MEN1 2115/4885
US-12534563-B2 Block copolymer, resin composition, stretch conductor, electronic device, and pressure-sensitive adhesive film EPB41, ITGB4, ITGB5 TSHR 657/4885MAPK1 1753/4885MEN1 3611/4885
US-12624279-B2 Quantum dot-containing polymerizable composition, cured product, wavelength conversion member, backlight unit, and liquid crystal display device NLRP1, NLRP3, ALAD TSHR 2197/4885MAPK1 2002/4885MEN1 3617/4885
US-12565548-B2 Compound, polymerizable composition, and cured product SEM1, PSMA1, RER1 TSHR 4589/4885MAPK1 983/4885MEN1 452/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.